Jul 1 |
Vivos eyes human trials for radiation treatment gel with IDE submission
|
Jun 27 |
Vivos gains as pilot program validates new market model
|
Jun 27 |
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
|
Jun 12 |
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
|
May 20 |
Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors
|
May 18 |
Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript
|
May 15 |
Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
May 15 |
Vivos Therapeutics GAAP EPS of -$1.63, revenue of $3.4M
|
May 14 |
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
|
May 14 |
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
|